Mortality measures to profile hospital performance for patients with septic shock

Critical Care Medicine

Volumn 46, Issue 8, 2018, Pages 1247-1254

  Walkey, Allan J ^a   Shieh, Meng Shiou ^b,c   Liu, Vincent X ^d   Lindenauer, Peter K ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Massachusetts Medical School   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

Health services research; Outcome assessment; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; HYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; VASOCONSTRICTOR AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; EMERGENCY CARE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ICD-9; INTENSIVE CARE; KAPPA STATISTICS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MORTALITY RATE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SEPTICEMIA; UNITED STATES; AGED; BENCHMARKING; CRITICAL ILLNESS; FEMALE; HEALTH CARE QUALITY; MALE; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; SEPSIS; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BENCHMARKING; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEPSIS; SHOCK, SEPTIC; UNITED STATES; VASOCONSTRICTOR AGENTS;

EID: 85056515628     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000003184     Document Type: Article

References (52)

1. Elixhauser A, Friedman B, Stranges E: Septicemia in U.S. Hospitals, 2009. Rockville, MD, HCUP Agency for Healthcare Research and Quality, 2011
2. Mayr FB, Talisa VB, Balakumar V, et al: Proportion and cost of unplanned 30-day readmissions after sepsis compared with other medical conditions. JAMA 2017; 317:530-531
3. Rowan KM, Angus DC, Bailey M, et al; PRISM Investigators: Early, goal-directed therapy for septic shock - a patient-level meta-analysis. N Engl J Med 2017; 376:2223-2234
4. Prescott HC, Langa KM, Liu V, et al: Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med 2014; 190:62-69
5. Marik PE, Linde-Zwirble WT, Bittner EA, et al: Fluid administration in severe sepsis and septic shock, patterns and outcomes: An analysis of a large national database. Intensive Care Med 2017; 43:625-632
6. Peltan ID, Mitchell KH, Rudd KE, et al: Physician variation in time to antimicrobial treatment for septic patients presenting to the emergency department. Crit Care Med 2017; 45:1011-1018
7. Lagu T, Rothberg MB, Nathanson BH, et al: Variation in the care of septic shock: The impact of patient and hospital characteristics. J Crit Care 2012; 27:329-336
8. Centers for Medicare & Medicaid Services: CMS Measures Inventory. Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/CMSMeasures-Inventory.html. Accessed June 8, 2017
9. QualityNet: Specifications Manual, Version 5.0b, Section 2.2. Severe Sepsis and Septic Shock. Available at: https://www.qualitynet.org/ dcs/ContentServer?c=Page&pagename=QnetPublic%2FPage%2F QnetTier4&cid=1228774725171. Accessed June 8, 2017
10. Wall MJ, Howell MD: Variation and cost-effectiveness of quality measurement programs. The case of sepsis bundles. Ann Am Thorac Soc 2015; 12:1597-1599
11. Seymour CW, Gesten F, Prescott HC, et al: Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 2017; 376:2235-2244
12. ACCP, AACN, GNYHA, MWCCC, NAMDRC, SAEM, SHM: Letter of Appeal on 0500 Severe Sepsis and Septic Shock: Management Bundle. Available at: www.qualityforum.org/WorkArea/linkit.aspx?Lin kIdentifier=id&ItemID=73103. Accessed June 21, 2017
13. Klompas M, Rhee C: The CMS sepsis mandate: Right disease, wrong measure. Ann Intern Med 2016; 165:517-518
14. Krumholz HM, Normand SL, Spertus JA, et al: Measuring performance for treating heart attacks and heart failure: The case for outcomes measurement. Health Aff (Millwood) 2007; 26:75-85
15. Iezzoni LI: The risks of risk adjustment. JAMA 1997; 278:1600-1607
16. Glance LG, Li Y, Dick AW: Quality of quality measurement: Impact of risk adjustment, hospital volume, and hospital performance. Anesthesiology 2016; 125:1092-1102
17. Glance LG, Osler TM, Dick AW: Identifying quality outliers in a large, multiple-institution database by using customized versions of the Simplified Acute Physiology Score II and the Mortality Probability Model II0. Crit Care Med 2002; 30:1995-2002
18. Shahian DM, Wolf RE, Iezzoni LI, et al: Variability in the measurement of hospital-wide mortality rates. N Engl J Med 2010; 363:2530-2539
19. Lindenauer PK, Lagu T, Shieh MS, et al: Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA 2012; 307:1405-1413
20. Rothberg MB, Pekow PS, Priya A, et al: Variation in diagnostic coding of patients with pneumonia and its association with hospital riskstandardized mortality rates: A cross-sectional analysis. Ann Intern Med 2014; 160:380-388
21. Angus DC, Seymour CW, Coopersmith CM, et al: A framework for the development and interpretation of different sepsis definitions and clinical criteria. Crit Care Med 2016; 44:e113-e121
22. Rhee C, Kadri SS, Danner RL, et al: Diagnosing sepsis is subjective and highly variable: A survey of intensivists using case vignettes. Crit Care 2016; 20:89
23. Singer M, Deutschman CS, Seymour CW, et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801-810
24. Rhee C, Murphy MV, Li L, et al; Centers for Disease Control and Prevention Epicenters Program: Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis 2015; 60:88-95
25. National Quality Forum: Measure Evaluation Criteria. Available at: http://www.qualityforum.org/Measuring-Performance/Submitting-Standards/Measure-Evaluation-Criteria.aspx. Accessed July 3, 2017
26. New York State Department of Public Health: New York State Report on Sepsis Care Improvement Initiative: Hospital Quality Performance. 2017. Available at: https://www.health.ny.gov/press/reports/docs/2015-sepsis-care-improvement-initiative.pdf. Accessed August 4, 2017
27. Kadri SS, Rhee C, Strich JR, et al: Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest 2017; 151:278-285
28. Centers for Medicare & Medicaid Services: Measure Methodology. 2018. Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/Measure-Methodology.html. Accessed June 22, 2017
29. Normand ST, Glickman ME, Gatsonis CA: Statistical applications for profiling providors of medical care: Issues and applications. J Am Stat Assoc 1997;92:803-814
30. Bratzler DW, Normand SL, Wang Y, et al: An administrative claims model for profiling hospital 30-day mortality rates for pneumonia patients. PLoS One 2011; 6:e17401
31. Elixhauser A, Steiner C, Harris DR, et al: Comorbidity measures for use with administrative data. Med Care 1998; 36:8-27
32. Glance LG, Dick AW, Osler TM, et al: Does date stamping ICD-9-CM codes increase the value of clinical information in administrative data? Health Serv Res 2006; 41:231-251
33. Gagne JJ, Glynn RJ, Avorn J, et al: A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol 2011; 64:749-759
34. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
35. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
36. Merlo J, Chaix B, Ohlsson H, et al: A brief conceptual tutorial of multilevel analysis in social epidemiology: Using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 2006; 60:290-297
37. Shrout PE, Fleiss JL: Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 1979; 86:420-428
38. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174
39. Walkey AJ, Lagu T, Lindenauer PK: Reply: Trends in sepsis and infection sources in the United States. A population-based study. Ann Am Thorac Soc 2015; 12:785
40. McNamara RL, Wang Y, Partovian C, et al: Development of a hospital outcome measure intended for use with electronic health records: 30-day risk-standardized mortality after acute myocardial infarction. Med Care 2015; 53:818-826
41. Suter LG, Li SX, Grady JN, et al: National patterns of risk-standardized mortality and readmission after hospitalization for acute myocardial infarction, heart failure, and pneumonia: Update on publicly reported outcomes measures based on the 2013 release. J Gen Intern Med 2014; 29:1333-1340
42. Bernheim SM, Grady JN, Lin Z, et al: National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes 2010; 3:459-467
43. Lindenauer PK, Bernheim SM, Grady JN, et al: The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for medicare beneficiaries with pneumonia. J Hosp Med 2010; 5:E12-E18
44. Krumholz HM, Wang Y, Mattera JA, et al: An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation 2006; 113:1683-1692
45. Lindenauer PK, Normand SL, Drye EE, et al: Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med 2011; 6:142-150
46. Iwashyna TJ, Odden A, Rohde J, et al: Identifying patients with severe sepsis using administrative claims: Patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis. Med Care 2014; 52:e39-e43
47. Prescott HC, Cope TM, Gesten FC, et al: Reporting of sepsis cases for performance measurement versus for reimbursement in New York State. Crit Care Med 2018; 46:666-673
48. California Office of Statewide Health Planning and Development, Healthcare: Community-Acquired Pneumonia: Hospital Outcomes in California, 1999-2001. Sacramento, CA, California Office of Statewide Health Planning and Development, 2004. Available at: http://www.oshpd.ca.gov/HID/Products/PatDischargeData/ ResearchReports/OutcomeRpts/CAP/Reports/1999-to-2001.html Edition
49. Li P, Kim MM, Doshi JA: Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortality. BMC Health Serv Res 2010; 10:245
50. Jolley RJ, Sawka KJ, Yergens DW, et al: Validity of administrative data in recording sepsis: A systematic review. Crit Care 2015; 19:139
51. Jolley RJ, Quan H, Jetté N, et al: Validation and optimisation of an ICD- 10-coded case definition for sepsis using administrative health data. BMJ Open 2015; 5:e009487
52. Gedeborg R, Furebring M, Michaëlsson K: Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients. J Clin Epidemiol 2007; 60:155-162